Toxicity Evaluation of a VLP-Based Vaccine Аgainst Human Rotavirus Infection Following a Single Administration in Rats: Serum Biochemistry and Histopathological Examination of Organs and Injection Site
Authors:
- Oleg V. LedenevOleg V. Ledenev
- Ilya E. FilatovIFIlya E. Filatov
- Olesya V. EliseevaOEOlesya V. Eliseeva
- Oleg E. LatyshevOLOleg E. Latyshev
- Igor A. DyachenkoIDIgor A. Dyachenko
- Gulsara A. SlashchevaGSGulsara A. Slashcheva
- Elvira R. ShaykhutdinovaESElvira R. Shaykhutdinova
- Ekaterina N. KazakovaEKEkaterina N. Kazakova
- Elena S. SadovnikovaESElena S. Sadovnikova
- Olga I. PatsapOPOlga I. Patsap
- Varvara V. LebedevaVLVarvara V. Lebedeva
- Arkady N. MurashevAMArkady N. Murashev
Open Access
- 15 August 2025
- journal article
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (8) , 69-79
Abstract
Virus-like particle (VLP) - based vaccines exhibit outstanding clinical, epidemiological, and immunological efficacy and specificity. The novel technology used for producing their active component without incorporating live viruses enables both injectable and non-injectable (e.g., intranasal) administration, emphasizing the need for a comprehensive safety assessment. This study is part of a preclinical toxicological evaluation program aimed at assessing the safety profile of the “Gam-VLP-rota” vaccine candidate targeting human rotavirus infection. The goal of this extended toxicology study was to confirm the safety of a single intramuscular administration of the vaccine in Sprague-Dawley rats. The study focused on identifying possible adverse effects both acutely (within 24 hours post-administration) and after a 14-day recovery period, aiming to detect delayed toxicological signs. Toxicological endpoints included evaluation of target organs, coagulation parameters, hematology, clinical biochemistry, necropsy findings, and histopathological analysis. This article presents a segment of the results, including changes in serum biochemical parameters after a single immunization and histological examination of internal organs and the injection site in rats. Keywords: VLP; vaccines; preclinical studies; vaccine safety; toxicological chemistry.Keywords
This publication has 40 references indexed in Scilit:
- Vaccination and Therapeutics2024
- Virus‐like particles as powerful vaccination strategy against human virusesReviews in Medical Virology, 2023
- Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple SclerosisMultiple Sclerosis and Related Disorders, 2022
- Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2Biotechnology Letters, 2021
- An innovative method of nonclinical efficacy and toxicological evaluation of recombinant Salmonella typhi Ty21a expressing HPV16 and 18 L1 proteinsMethodsX, 2021
- Topical review on nano-vaccinology: Biochemical promises and key challengesProcess Biochemistry, 2021
- Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing, ChinaJournal of Medical Virology, 2020
- Exploiting virus-like particles as innovative vaccines against emerging viral infectionsJournal of Microbiology, 2017
- Virus like particle-based vaccines against emerging infectious disease virusesVirologica Sinica, 2016
- Bioengineering virus‐like particles as vaccinesBiotechnology and Bioengineering, 2013